| Assay Method Information | |
| | Activity of Exemplary Compounds in an In Vitro Model of Vanishing Cell White Matter Disease (VWMD) |
| Description: | In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was prepared by fusing the human full-length ATF4 5′-UTR (NCBI Accession No. BC022088.2) in front of the firefly luciferase (FLuc) coding sequence lacking the initiator methionine as described in Sidrauski et al (eLife 2013). The construct was used to produce recombinant retroviruses using standard methods and the resulting viral supernatant was used to transduce HEK293T cells, which were then subsequently selected with puromycin to generate a stable cell line. |
| Affinity data for this assay | |
|---|---|
| If you find an error in this entry please send us an E-mail | |